PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,686,556 | multicentr longitudin observ cohort studi examin relationship neutrophil function sepsi adult children sever thermal injuri protocol scientif investig biolog pathway follow thermal injuri sifti studi burn induc chang phenotyp function neutrophil cell provid front line protect rapid divid bacteri infect emerg potenti biomark earli predict sepsi longitudin studi adult burn patient recent demonstr combin measur neutrophil phagocyt capac immatur granulocyt ig count plasma cell free dna cfdna level day injuri gave good discriminatori power predict later sepsi develop howev limit small sampl size singl centr design focus adult burn patient biomark requir prospect valid larger patient cohort scientif investig biolog pathway follow thermal injuri studi aim prospect valid neutrophil phagocyt activ ig count plasma cfdna level earli prognost biomark sepsi thermal injur adult paediatr patient | D002056;D018805 | T047;T037;T046 |
34,686,555 | total hip arthroplasti versus progress resist train patient sever hip osteoarthr protocol multicentr parallel group randomis control superior trial hip osteoarthr oa lead caus total hip arthroplasti tha although consid surgeri centuri patient report long term pain deficit physic function muscl strength may persist tha progress resist train prt appear improv multipl outcom moder patient hip oa current treatment select base low level evid randomis control trial compar tha non surgic treatment primari aim trial investig whether tha follow standard care superior week supervis prt follow week option unsupervis prt improv hip pain function patient sever hip oa | D019644;D015207;D055070 | T047;T061 |
34,686,554 | observ studi relat efficaci insulin glucos treatment hyperkalaemia patient liver cirrhosi determin liver cirrhosi associ reduc efficaci insulin glucos treatment moder sever hyperkalaemia | D058625;D006947 | T033;T047 |
34,686,553 | preval factor associ diabet mellitus among tuberculosi patient south india cross section analyt studi determin preval determin diabet mellitus dm among tuberculosi tb patient assess addit yield number need screen nns obtain newli diagnos dm among tb patient | D003920;D014376;D014397 | T047 |
34,686,552 | learnt qualit evalu implement rapid sexual health test diagnosi treatment servic investig experi implement new rapid sexual health test diagnosi treatment servic | D000074384;D012749 | T032;T047 |
34,686,551 | cost effect household contact investig detect tuberculosi pakistan despit guidelin recommend household contact investig studi show impact activ screen tuberculosi tb programm resourc limit set carri passiv contact investig cost strategi often cite barrier implement howev littl data avail addit cost requir implement strategi aim estim cost cost effect activ contact investig compar passiv contact investig urban pakistan | D016358;D014376 | T058;T047 |
34,686,550 | strengthen mental health servic swedish youth clinic health polici system studi protocol strengthen first line mental healthcar servic youth remain prioriti swedish govern govern current investig differ sector involv strengthen evid scarc youth clinic play key role discuss one trust servic youth howev analysi organis function coordin servic import strengthen youth clinic role first line mental healthcar studi investig challeng aim analys integr mental healthcar within youth clinic identifi strategi strengthen first line mental healthcar youth sweden | D016497;D008605 | T058 |
34,686,549 | paediatr tuberculosi prevent treatment prefer among hiv posit children caregiv healthcar provid eswatini discret choic experi isoniazid prevent therapi initi complet rate suboptim among children shorter tuberculosi tb prevent treatment tpt regimen demonstr safeti efficaci children may improv adher wide use high tb burden countri understand prefer regard tpt regimen characterist servic deliveri model key design servic improv tpt initi complet rate examin paediatr tpt prefer eswatini high tb burden countri | D015658;D014376 | T047 |
34,686,548 | gut microbiom enter infect child growth across rural urban gradient protocol ecomid prospect cohort studi function consequ bacteri gut microbiom child health well understood characterist earli child gut microbiom may influenc cours enter infect enter infect may chang composit gut microbiom may long term implic child growth develop | D000069196;D064307 | T028;T007;T032;T001 |
34,686,547 | recruit perspect experi trial recruit process qualit evid synthesi protocol recruit randomis trial rcts often challeng review intervent improv recruit highlight pauciti effect intervent aim recruit need research area understand perspect experi involv rct recruit help identifi barrier facilit recruit subsequ inform futur intervent support recruit protocol describ method propos qualit evid synthesi qes recruit perspect experi relat rct recruit | D018579;D036301 | T058;T080;T062 |
34,686,545 | high p inka marker cellular senesc associ renal injuri impair outcom lupus nephriti signific fraction patient lupus nephriti ln develop renal impair need better understand mechan under diseas progress assess cellular senesc ln kidney associ diseas sever outcom | D019941;D008181 | T116;T047;T123 |
34,686,534 | tempor trend routin predischarg puls oximetri screen year experi uk region neonat unit evalu continu impact puls oximetri screen pos region neonat unit nnu identifi trend screen outcom comparison previous experi | D006330;D015997 | T019;T061 |
34,686,533 | surfact therapi late preterm term neonat respiratori distress syndrom systemat review meta analysi evid base recommend surfact use late preterm lpt term infant respiratori distress syndrom rds | D011663;D012127 | T047;T121;T109;T123 |
34,686,531 | recurr glomerular diseas kidney transplant diagnost manag dilemma recurr glomerular diseas kidney transplant remain import caus allograft failur mani differ entiti post transplant still suffer incomplet knowledg pathophysiolog therefor lack target effect therapi review focus specif clinic dilemma encount physician manag recurr glomerular diseas highlight new insight understand treatment post transplant focal segment glomerulosclerosi membran nephropathi atyp hemolyt urem syndrom c glomerulopathi amyloid light chain al amyloidosi iga nephropathi | D016030 | T061 |
34,686,530 | mrgfus mediat antibodi deliveri improv drug uptak across bbb mrgfus deliv trastuzumab demonstr safeti efficaci treat brain metastas | D001812;D001932 | T191;T023 |
34,686,529 | mutant clone adjac normal epithelium limit earli tumorigenesi mutant clone normal epithelium limit earli format esophag tumor mice | D004938 | T191 |
34,686,528 | gut microbiota drive androgen resist prostat cancer gut microbiota drive hormon resist castrat resist prostat cancer crpc | D000069196;D064129 | T007;T191;T001 |
34,686,527 | dual cdcd car cell show feasibl pediatricyoung adult b dual target car cell show safeti efficaci pediatricyoung adult relaps refractori b | D018941;D016219;D015452;D051918 | T129;T191;T116;T061 |
34,686,526 | sub tumor microenviron influenc pdac progress therapi respons two distinct tumor microenviron tme state exist pancreat cancer link patient outcom | D021441;D010190 | T191 |
34,686,523 | molecular regul bile acid homeostasi bile acid known decad aid digest absorpt dietari fat fat solubl vitamin intestin develop gene knockout mice model transgen human mous model help us understand function bile acid role modul fat glucos energi metabol molecular regul synthesi transport homeostasi bile acid g protein coupl receptor tgr regul bile acid induc alter intermediari metabol wherea nuclear receptor fxr regul bile acid synthesi homeostasi howev review indic unidentifi factor addit fxr must exist aid regul bile acid synthesi homeostasi signific statement review captur present understand bile acid synthesi role bile acid transport enterohepat circul bile acid role nuclear receptor fxr regul bile acid synthesi bile acid transport import bile acid activ gpcr signal via tgr modifi intermediari metabol inform use develop drug treatment various hepat intestin diseas well metabol syndrom | D001647;D015398 | T043;T044;T109;T123 |
34,686,522 | ontogeni scale factor pediatr physiolog base pharmacokinet model simul microsom protein per gram liver microsom protein per gram liver mppgl import scale factor bottom physiolog base pharmacokinet model simul data pediatr limit therefor mppgl determin liver sampl pediatr n adult n donor obtain four sourc univers maryland brain tissu bank umbtb tissu retriev servic univers minnesota univers pittsburgh sekisui xenotech tissu homogen subject differenti centrifug prepar microsom cytochrom c reductas activ tissu homogen microsom use estim cytochrom p reductas por activ marker microsom recoveri microsom por content also assess quantit proteom mppgl valu vari fold within various age groupsdevelopment stage tissu sourc identifi contribut factor use trim dataset compris sampl rang year age common four sourc por protein abund activ microsom por activ homogen lower umbtb sampl autopsi compar sourc perfusedflash frozen regress analys reveal umbtb sampl drive appar age effect effect age log transform mppgl valu observ umbtb sampl exclud conclud meansd mppgl valu mgg repres one month postnat age earli adulthood potenti sourc effect consid studi involv tissu sampl multipl sourc differ procur process procedur signific statement microsom protein per gram liver mppgl import scale factor bottom pbpk model simul data pediatr limit although mppgl vari fold given development stage valu mgg mean sd repres one month postnat age earli adulthood howev tissu sampl obtain multipl sourc differ procur process procedur may influenc result taken consider | D010599 | T062;T039 |
34,686,519 | covid induc new onset diabet trend technolog coronavirus diseas covid global pandem continu spread worldwid approxim million confirm case million death date intens effort ongo combat diseas suppress viral transmiss understand pathogenesi develop vaccin strategi identifi effect therapeut target individu preexist diabet also show higher incid covid ill poorer prognosi upon infect likewis increas frequenc diabet onset diabet complic report patient follow covid diagnosi covid may elev risk hyperglycemia complic patient without prior diabet histori unclear whether virus induc type type diabet instead caus novel atyp form diabet moreov remain unknown recov covid patient exhibit higher risk develop new onset diabet complic go forward aim review summar current known epidemiolog mechan bidirect relationship covid diabet highlight major challeng hinder studi covid induc new onset diabet propos potenti framework overcom obstacl also review state art wearabl microsampl technolog studi diabet manag progress new onset diabet case conclud outlin current research initi investig bidirect relationship covid diabet emphasi wearabl technolog | D000086402 | T005 |
34,686,512 | effect pandem isol alcohol psychoact medic use popul rehabilit pain patient conjunct coronavirus diseas lockdown use illicit drug suggest potenti increas drug usag opioid death studi felt need examin lockdown caus chang drug intak popul substanc abus pain manag patient | D000428;D012934 | T054;T055 |
34,686,509 | multipl mutat detect risk assess patient breast cancer use next generat sequenc breast cancer recogn common caus malign cancer death worldwid howev mutat cancer relat brca gene detect patient breast cancer next generat sequenc technolog allow concurr sequenc numer target gene divers cancer suscept gene evalu although signific clinic practic remain unclear | D009154 | T045 |
34,686,499 | activ notch myc signal via b cell restrict deplet dnmta generat consist murin model chronic lymphocyt leukemia chronic lymphocyt leukemia cll character disord dna methyl suggest epigenet chang might play critic role diseas onset progress methyltransferas dnmta key regul dna methyl although dnmta somat mutat cll rare found low dnmta express associ aggress diseas condit knockout mous model show homozyg deplet dnmta b cell result develop cll penetr median age onset month heterozyg dnmta deplet yield diseas penetr median onset month confirm role haploinsuffici tumor suppressor ba cell confirm cell origin diseas model dnmta deplet result focal hypomethyl activ notch myc signal amplif chromosom contain myc gene detect cll mice test infiltr high myc express cll cell spleen observ notabl hyperactiv notch myc signal exclus observ dnmta cll mice three cll mous model test sfb atm ikzf mdr dnmta deplet cll sensit pharmacolog inhibit notch signal vitro vivo consist find human cll sampl lower dnmta express sensit notch inhibit higher dnmta express altogeth result suggest dnmta deplet induc cll high depend activ notch myc signal signific loss dnmta express drive event cll associ aggress diseas activ notch myc signal enhanc sensit notch inhibit | D004195;D019008 | T042;T050;T038 |
34,686,497 | associ pd pd l co locat immunotherapi outcom non small cell lung cancer program cell death protein pd program death ligand pd l interact suppress local cell respons promot peripher toler current studi focus pd pd l co locat surrog interact assess associ immunotherapi outcom patient non small cell lung cancer nsclc | D002289;D008175 | T191 |
34,686,496 | trend inpati admiss emerg depart visit heart failur adult versus without diabet usa heart failur hf major contributor cardiovascular morbid mortal peopl diabet studi estim trend incid hf inpati admiss emerg depart ed visit diabet status | D003920;D006333 | T047;T046 |
34,686,494 | ficolin valuabl biomark identifi leukaemia juvenil idiopath arthriti distinct clinic ground acut lymphoblast leukaemia present arthropathi arthropathi juvenil idiopath arthriti jia difficult clinic paraclin sign leukaemia may vagu primari aim examin use lectin complement pathway protein marker differenti arthropathi jia secondari aim compar protein level baselin follow pair number children examin correl haematolog count erythrocyt sediment reaction esr c reactiv protein crp blast relaps death | D001171;D007938 | T191;T047 |
34,686,488 | neoadjuv sting activ extend half life il checkpoint blockad promot metastasi clearanc via sustain nk cell activ combin immunotherapi treatment recruit innat adapt immun potenti increas cancer respons rate engag complet repertoir effector mechan combin intratumor stimul interferon gene sting agonist therapi system inject extend half life il anti pd checkpoint blockad hereaft cip therapi drive innat adapt antitumor immun model tripl negat breast cancer unlik treatment individu compon trival immunotherapi halt primari tumor progress led long term remiss major anim two spontan metastas orthotop breast tumor model though neoadjuv therapi adjuv therapi cip therapi induc antitumor cell respons protect metastat relaps depend natur killer nk cell combin sting agonist ilanti pd synerg stimul sustain granzym cytokin express lung infiltr nk cell type ifn generat result sting agon combin il act posit feedback loop enhanc express ifnar cd lung nk cell result suggest nk cell therapeut target effect elimin tumor metastas see relat spotlight demaria p | D020360 | T061 |
34,686,487 | summaris verifi access improv clinic inform manag potenti haematopoiet stem cell transplant patient welsh transplant immunogenet laboratori wtail respons manag patient work haematopoiet stem cell transplant hsct potenti curat option mani haematolog non haematolog condit work requir regular communic wtail transplant clinician facilit week multidisciplinari team mdt meet agre decis proceed work stage effect communic minimis error critic transplant cell suboptim donor could sever fatal consequ patient review hsct patient manag identifi issu includ staff dissatisfact ineffici current paper base system concern potenti incid caus error manual transcript patient inform track clinic decis anoth driver chang covid pandem prevent usual face face mdt meet staff would show clinician paper record report shift onlin mdt requir new way share data project develop new central refer point patient manag data along electron patient summari sheet design eye improv safeti effici sever improv cycl test refin summari sheet staff clinician experi videoconferenc facilit data share conduct interview staff conclud new process success reduc transcript duplic improv communic clinician pandem despit increas workload due build activ patient work case pandem staff report new summari enabl cope well key initi creation task finish group help establish continu improv cultur identifi addit area improv follow improv project | D000086382;D018380 | T047;T061;T067 |
34,686,486 | explor mean role experi patient led social innov peopl affect cancer new collabor care model complement tradit cancer rehabilit sweden kraften hus first support centr sweden design peopl affect cancer includ patient famili friend staff member local communiti repres collect stakehold purpos studi explor mean role experi kraften hus stakehold use patient public involv methodolog | D009369 | T191 |
34,686,480 | idiopath combin adrenocorticotropin growth hormon defici mimick chronic fatigu syndrom year old man suffer sever fatigu year diagnos chronic fatigu syndrom cfs fibromyalgia endocrinolog workup use combin anterior pituitari function test show patient adrenocorticotropin hormon acth defici normal pituitari mri treatment physiolog dose oral hydrocortison replac physic amelior general fatigu secondari workup use growth hormon releas peptid test reveal also growth hormon gh defici gh replac therapi start muscl pain depress improv therapi present rare case combin defici acth gh middl age man sever general fatigu case report aim rais awar combin defici acth gh differenti diagnosi cfs mimic | D015673 | T047 |
34,686,479 | two dose covid vaccin possibl arthriti flare among patient rheumatoid arthriti hong kong investig relationship covid full vaccin two complet dose possibl arthriti flare | D000067251 | T033;T184 |
34,686,476 | evalu suitabl clinic applic differ electrod aeegceeg monitor extrem prematur infant monitor brain function use continu electroencephalographi aeegceeg essenti tool standard care term infant use grow prematur infant biomark lesion brain matur howev place electrod great challeng particular extrem prematur infant often discourag neuromonitor aim studi assess differ electrod avail select one best suit peculiar extrem prematur infant evalu applic clinic practic | D004569;D062071 | T100;T034;T060 |
34,686,474 | develop valid weak supervis deep learn framework predict status molecular pathway key mutat colorect cancer routin histolog imag retrospect studi determin status molecular pathway key mutat colorect cancer crucial optim therapeut decis make therefor aim develop novel deep learn pipelin predict status key molecular pathway mutat whole slide imag haematoxylin eosin stain colorect cancer slide altern current test | D015179;D000077321;D053842;D009154;D010641 | T049;T191;T066;T045;T032 |
34,686,472 | swog phase iiiii random studi r minichop without oral azacitidin cc particip age year older newli diagnos aggress non hodgkin lymphoma aim improv therapi outcom valid prospect frailti tool diffus larg b cell lymphoma dlbcl aggress potenti curabl malign howev cure high depend abil deliv intens anthracyclin base chemoimmunotherapi near one third case dlbcl occur patient age year advanc age import advers featur prognost model despit incid older patient clear accept standard care due represent group larg random clinic trial furthermor insuffici assess baselin frailti predict toxic hamper clinic decis make present ongo random studi r minichop chemoimmunotherapi without oral azacitidin cc onureg patient age older newli diagnos dlbcl associ aggress lymphoma incorpor oral hypomethyl agent base increas tumor methyl biolog featur older patient dlbcl desir minim inject burden popul first random studi popul conduct north america nation clinic trial network nctn enrol patient includ patient safeti run phase studi incorpor object assess baselin frailti fil tool serial comprehens geriatr assess cga key correl test includ circul tumor dna ctdna assay pre specifi timepoint explor ctdna quantiti methyl pattern correl respons potenti impact futur trial design chang standard care patient year older aggress lymphoma given random design prospect incorpor geriatr assess explor ctdna correl trial registr trial regist clinicaltrialgov identifi nct | D000073496;D016403;D008228 | T033;T191;T046;T184 |
34,686,471 | misdiagnosi type diabet mellitus use continu glucos monitor improv patient center care american diabet associ recommend glycosyl hemoglobin ac assess manag diabet mellitus dm provid specif ac goal reduc risk dm relat complic although ac conveni test diagnos monitor dm manag month time frame certain condit may affect accuraci ac | D015190;D003924 | T047;T060 |
34,686,470 | evid base urolog surrog endpoint use intermedi clinic endpoint overal surviv surrog shorten trial durat relat cost would potenti allow earlier introduct practic novel practic chang medic treatment consequ impact patient prognosi | D014572 | T091 |
34,686,468 | good surgeon debat public avail individu outcom data urolog con public report consultantstaff urologist outcom must reli common perform procedur accur data input adequ fund precaut must taken ensur inform utilis best interest inform public surgeon | D066231;D014572 | T097;T091 |
34,686,466 | berberin mitig nonalcohol hepat steatosi downregul sirt foxo srebp pathway cholesterol synthesi investig effect berberin bbr cholesterol synthesi hepg cell free fatti acid ffa induc steatosi explor under mechan | D001599;D065626 | T047;T121;T109 |
34,686,465 | erap emerg therapeut target medulloblastoma endoplasm reticulum aminopeptidas erap multifunct enzym shape peptid repertoir present major histocompat complex class mhc molecul therebi affect tumor immunogen erap alter mani tumor includ medulloblastoma mb review role erap mb develop possibl target enzym mb treatment | D002528;D008527 | T191 |
34,686,464 | deep learn lung diseas segment ct reconstruct kernel use purpos studi determin whether singl reconstruct kernel high low frequenc kernel use train deep learn model segment diffus lung diseas chest comput tomographi ct | D000086382;D000077321 | T047;T066;T067 |
34,686,461 | colchicin prevent periprocedur myocardi injuri percutan coronari intervent cope pci descript cytokin pilot sub studi high level inflamm pre post percutan coronari intervent pci associ wors outcom recent trial suggest benefit treat inflamm colchicin coronari arteri diseas randomis pilot cope pci sub studi aim determin administr colchicin pre pci would attenu inflammatori effect pci | D006335;D062645 | T061;T037 |
34,686,460 | habitu sleep sleep durat differenti weight chang among adult find wisconsin sleep cohort studi assess longitudin associ diari measur sleep durat clinic assess bodi mass index bmi | D012890 | T040;T033 |
34,686,459 | clinic applic urinari creatinin clearanc determin initi dose vancomycin critic ill patient purpos studi evalu clinic applic urinari creatinin clearanc crcl determin initi dose vancomycin vcm critic ill patient assess vcm trough plasma concentrationmainten daili dose cd ratio patient augment renal clearanc arc | D051437;D014640 | T116;T047;T195 |
34,686,456 | moh micrograph surgeri cutan malign hand upper limb rais awar applic advantag moh micrograph surgeri mms primarili recognis use facial tumour howev also consid aid excis tumour hand preserv tissu mainten function key factor moh surgeri serv facilit decis make patient surgeon particular help propos extens surgeri prior complex reconstruct confirm tumour clearanc paramount use case exampl medic imag illustr advantag mms convent excis establish mms hand servic deliv surgeon specialist upper limb resect reconstruct expertis allow unit provid optim treatment govern outcom group patient | D005153;D012878 | T191 |
34,686,454 | femal sex affect complex endovascular aortic repair singl centr cohort studi grow evid femal patient disadvantag complex endovascular aortic repair use fenestr branch endograft fb evar primarili relat peri procedur event includ ischaem access vessel complic studi aim determin impact sex differ treatment pattern hospit outcom singl centr cohort | D019917;D057510 | T061 |
34,686,447 | second autolog stem cell transplant salvag multipl myeloma oregon health scienc univers experi second autolog transplant sat routin perform set myeloma relaps though data outcom lack conduct singl center review multipl myeloma patient ohsu receiv sat exclud tandem respons assess intern myeloma work group imwg criteria | D018380;D009101 | T191;T061 |
34,686,446 | valid aml score older adult receiv cpx intens induct chemotherapi treatment secondari acut myeloid leukemia aml score valid patient receiv tradit induct chemotherapi cpx conduct retrospect analysi evalu among patient secondari acut myeloid leukemia receiv intens induct cpx aml score associ complet remiss cr earli mortal em within day induct | D060828;D015470 | T191;T061 |
34,686,445 | efficaci safeti ct p versus rituximab untreat low tumor burden follicular lymphoma final result random phase iii studi doubl blind parallel group activ control phase iii trial nct assess ct p rituximab safeti efficaci patient previous untreat low tumor burden follicular lymphoma ltbfl includ singl switch rituximab ct p | D058846;D008224 | T129;T191;T116 |
34,686,444 | sar coronavirus seropreval asymptomat healthi blood donor indic communiti spread corona virus diseas covid pandem caus sar corona virus sar cov major concern world serolog surveil import tool assess spread infect communiti studi attempt assess preval antibodi sar cov among blood donor delhi india pre vaccin period | D016036 | T062;T081 |
34,686,439 | score new updat algorithm predict cardiovascular diseas risk europ recent publish guidelin european societi cardiolog prevent cardiovascular diseas present august virtual european societi cardiolog congress recommend use score risk index instead classic score risk index calcul cardiovascular risk specif ten year fatal nonfat risk healthi popul age year level evid ib new risk index develop collabor investig includ cohort countri particip cover known risk factor heart circulatori diseas age sex lipid level blood pressur smoke addit divid countri four group risk use compet risk model adjust risk probabl anoth event enabl better estim risk fatal nonfat event younger popul year | D002309;D002318 | T091;T047 |
34,686,438 | eleven year venoven extracorpor membran oxygen acut respiratori distress syndrom hn sar cov experi perspect nation referr center despit grow expertis wide applic venoven extracorpor membran oxygen vv ecmo treatment acut respiratori distress syndrom ard differ origin pandem hn influenza virus sar cov larg report pertain most multicent registri random trial difficult perform aim studi report outcom trend innov vv ecmo treatment last year | D000086382;D015199;D053118;D012128 | T047;T005;T061;T067 |
34,686,436 | issu affect young peopl asthma transit period adult care asthma among common medic condit affect children young peopl adolesc recognis period increas risk overrepres analys examin recent increas asthma mortal rate asthma may chang signific period manag also occur context patient seek increas autonomi self govern whilst navig increas academ social demand number diseas factor destabilis asthma adolesc includ increas rate anaphylaxi anxieti depress obes femal emerg resist corticosteroid pro inflammatori effect oestrogen patient factor smoke vape poor symptom recognit treatment non adher variabl engag health servic contribut difficult treat asthma signific defici current approach transit identifi recent eaaci task forc subsequ asthma specif recommend publish provid import framework move forward chronic condit effect transit programm plan ahead engag adolesc famili identifi patient manag prioriti current challeng experienc treatment transit need may vari signific across asthma patient complex asthma may includ dedic transit clinic involv multidisciplinari care requir input includ amongst other allergi immunolog psycholog medicin respiratori physician scientist nurs specialist across differ global region barrier treatment may vari need elicit individualis approach taken optimis asthma care sustain within local adult healthcar system | D001249 | T047 |
34,686,433 | menopaus hormon therapi women benign gynaecolog condit cancer efficaci menopaus hormon therapi bothersom menopaus symptom well establish howev rang benign malign gynaecolog condit pose challeng manag menopaus symptom hormon depend natur either rais concern symptom recurr malign diseas progress make decis menopaus hormon therapi complex clinician patient appear small potenti symptom recurr menopaus hormon therapi use menopaus women histori sever endometriosi malign transform previous endometriot lesion like rare adequ understood set combin hormon therapi prefer includ woman post hysterectomi uterin fibroid contraind menopaus hormon therapi use women larg fibroid menopaus regular follow fibroid general menopaus hormon therapi consid appropri women cervic cancer ovarian cancer except low grade serous tumour endometri cancer requir individualis discuss overal qualiti data area poor suggest women low risk recurr may consid hormon therapi balanc symptom impact prognosi | D004715;D009369 | T191;T047 |
34,686,432 | pilot studi investig effect extend contact len wear limbal central corneal morpholog investig effect long term extend soft contact len wear limbal central corneal cell morpholog limbal architectur | D003263;D003315 | T023;T074 |
34,686,431 | correl long term use rigid gas permeabl contact lens endotheli morphometr chang keratoconus patient studi conduct evalu effect long term use rigid gas permeabl rgp contact lens corneal endothelium keratoconus kc patient use non contact specular microscopi addit correl wear durat rgp lens year hour endotheli morphometr chang kc patient perform may provid use data clinic applic rgp contact len | D003261;D007640 | T047;T074 |
34,686,430 | review year soft contact len wearer ocular physiolog data sinc introduct silicon hydrogel sihi contact lens year ago industri continu modifi len materi design len care product manufactur process strive improv contact len physiolog perform comfort conveni wearer purpos studi investig whether ocular health habitu soft contact len wearer today better previous decad | D003263 | T074 |
34,686,429 | surviv benefit chemotherapi contemporari cohort metastat urach carcinoma reli contemporari surveil epidemiolog end result seer databas test hypothesi chemotherapi may improv surviv metastat urach carcinoma urac | D002295;D001749 | T191 |
34,686,424 | efficaci modifi levat muscl resect use putterman ptosi clamp versus tradit levat muscl resect aponeurot ptosi retrospect analysi recent year modifi levat muscl resect use putterman ptosi clamp develop use retrospect case control studi compar effect modifi tradit levat muscl resect method | D019882;D001763 | T047;T061 |
34,686,423 | vertebr wnta crossroad cellular signal wnt signal essenti pathway embryogenesi differenti cell motil develop adult tissu homeostasi vertebr wnt signal network activ sever downstream pathway catenin depend tcflef transcript wntplanar cell polar pcp pathway wntcalcium pathway wnta vertebr wnt ligand often associ wntpcp signal pathway wntapcp signal well describ role embryogenesi via bind receptor complex frizzl co receptor initi downstream activ c jun n termin kinas jnk signal cascad rho rac gtpase rho kinas rock activ result cytoskelet remodel requir cell polar migrat subsequ tissu arrang organ format review focus recent work reveal new role wnta ligand consequ emerg broader function part due grow understand crosstalk wntpcp pathway wnt catenin pathway signal pathway part due identif novel atyp receptor wnta demonstr far broader role ligand | D051153;D060449 | T044;T116;T123 |
34,686,422 | degrad without ubiquitin new function parasit effector like mani pathogen oblig parasit bacteria phytoplasma repli secret effector caus diseas plant host huang et al reveal phytoplasma effector degrad plant protein independ ubiquitin bypass degrad step make arabidopsi thaliana plant resist parasit effector | D017360;D010271;D045582 | T204;T007;T002 |
34,686,421 | anthropogen chang associ impact vector born diseas urban impact communiti composit abund rich mosquito urban process increas global import better understand biodivers loss caus anthropogen chang associ impact vector born diseas mosquito surveil control key reduc risk mosquito born pathogen transmiss | D000330;D003715;D000079426;D000071244;D000071243 | T204;T047;T005 |
34,686,420 | fibro osseous pseudotumor aris nail bed great toe rare case recurr fibro osseous pseudotumor fopt rare rapid enlarg benign soft tissu neoplasm present local pain swell red typic present hand much less frequent feet fopt character histolog foci osseous differenti within prolifer fibroblast must differenti benign malign lesion fopt toe describ report recurr follow surgic excis extrem rare report young healthi femal patient present rapid grow fopt left great toe unusu case recur twice follow surgic excis within month period time lesion complet excis recurr follow up month conclus fopt rare soft tissu lesion toe featur fibroblast prolifer osseous differenti need differenti benign malign tumor standard treatment complet surgic excis excel prognosi | D001847;D006214;D012983 | T191;T023;T047 |
34,686,419 | impact tailor train pressur injuri nurs knowledg level pressur injuri point preval case turkey studi conduct determin impact tailor train provid nurs prevent pressur injuri pis nurs knowledg level pi point preval pp | D009726;D003668 | T097;T047 |
34,686,418 | women return use frozen oocyt year follow women plan oocyt cryopreserv reproduct choic retrospect reflect women least year plan oocyt cryopreserv poc | D015925;D059247;D054315 | T059;T061 |
34,686,414 | use intraop compar fluoroscopi allow assess sagitt reduct predict syndesmosi reduct ankl fractur intraop fluoroscop paramet shown poor predictor ankl syndesmosi reduct syndesmot malreduct smr report literatur anteroposterior tibio fibular index aptf previous describ evalu sagitt tibiofibular align later ankl radiograph high correl ankl uninjur subject reproduc intraop measur sagitt syndesmot reduct lack propos use captf calcul absolut differ aptf non injur oper ankl evalu sagitt syndesmot reduct | D064386;D016512 | T037 |
34,686,413 | cardiac surgeri patient blood disord blood disord contribut abnorm bleed detriment effect cardiac surgeri patient known patholog investig thorough cautious measur would need taken cardiac surgeri need cohort major current literatur cardiac surgeri patient von willebrand diseas haemophilia case report nevertheless evid show optimis factor level pre intra postop offer outcom similar patient without disord preoper screen follow appropri iron therapi reduc mortal patient anaemia group haemoglobin level improv postop iron supplement manag strategi cardiac surgeri peopl blood disord requir multidisciplinari approach high individualis patient essenti adequ adjust preoper periop postop care patient blood disord order achiev outcom similar patient without blood disord | D000740;D006348 | T047;T061 |
34,686,412 | efficaci safeti gastric peror endoscop myotomi g poem refractori gastroparesi year follow result gastroparesi common easili overlook diseas gastric peror endoscop myotomi g poem one third space endoscopi techniqu treat gastroparesi studi aim evalu efficaci safeti g poem patient refractori gastroparesi | D004931;D018589;D000074882 | T047;T061 |
34,686,411 | magnet reson imag role diagnos type endolymphat hydrop studi util recent advanc techniqu mr imag establish role diagnos type endolymphat hydrop eh | D018159;D034381;D008575 | T033;T047 |
34,686,407 | magnet reson relaxometri liver new imag biomark assess right heart failur pulmonari hypertens right heart failur rhf pulmonari hypertens ph patient manifest increas right atrial ra pressur hypothes liver relax time measur cardiovascular magnet reson cmr use noninvas assess increas right side fill pressur | D057791;D008279 | T170;T059;T060 |
34,686,406 | design rational discov global registri type diabet real world insight treatment pattern relationship cardiovascular renal metabol multimorbid discov global registri dgr aim provid insight patient attribut treatment pattern patient type diabet mellitus tdm seen clinic practic understand pattern impact treatment strategi cardio renal metabol multimorbid aim augment real world evid base creat discov studi | D012042 | T170 |
34,686,405 | examin effect clu apo polymorph combin coronari arteri diseas complex type diabet mellitus coronari arteri diseas cad type diabet mellitus tdm import increas public health problem studi aim identifi impact apo clu gene polymorph preval diseas along effect polymorph lipid profil glucos metabol | D001057;D051152;D003324;D003924 | T116;T047;T129;T123 |
34,686,404 | radiofrequ versus microwav ablat intraop treatment colorect liver metastas intraop radiofrequ ablat rfa newer techniqu microwav ablat mwa addit valu parenchyma preserv surgic treatment colorect liver metastas crlm mwa less influenc heat sink effect surround vessel generat heat less time rfa still wide use true compar studi scarc | D017115;D015179;D008113;D000078703 | T191;T061 |
34,686,403 | automat one click plan hippocamp avoid whole brain irradi raystat studi aim verifi accuraci auto contour auto dose optim hippocamp avoid whole brain radiat therapi ha wbrt head comput tomographi ct imag patient select region interest contain brain hippocampus eye lacrim gland contour manual automat ct imag compar evalu concord rate use simpson coeffici verifi perform dose optim auto dose plan compar manual plan case optim plan perform use volumetr modul arc therapi techniqu automat contour brain show high concord rate manual contour brain simpson coeffici contrast concord rate hippocamp contour low right left howev rate improv right left addit mm margin plan target volum prescrib dose dmean signific differ automat manual plan gy vs gy p gy vs gy p respect signific better manual plan automat plan gy vs gy p dmax hippocampus show signific differ automat manual plan gy right left vs gy p gy vs gy p respect accuraci auto contour ha wbrt guarante provid appropri margin precis auto dose optim compar manual plan | D001932;D050397 | T191;T061 |
34,686,402 | effect use virtual realiti breast biopsi pain anxieti random control trial virtual realiti vr nonpharmacolog method use healthcar set studi aim determin effect distract vr pain anxieti fine needl aspir fna breast biopsi | D010146;D000076142 | T066;T184 |
34,686,401 | explor predict model defens health agenc depart veteran affair beneficiari dietari supplement use purpos studi predict dietari supplement ds use among defens health agenc dha veteran affair va beneficiari schedul surgic procedur | D014728 | T098 |
34,686,400 | periop pain manag surgic patient opioid use disord program develop initi last decad increas number individu diagnos opioid use disord oud state level regulatori pressur mount develop capabl provid opioid free anesthesia ofa clinic indic patient request | D000758;D009293 | T048;T061 |
34,686,399 | cutan mammari loxoscel unknown caus breast inflamm case report review literatur envenom due loxoscel spider bite rare event franc case concern breast yet report report case year old woman present saint etienn univers hospit pulsatil pain left breast two day feel fleet bite abscess diagnos antibiot prescrib day later necrot zone appear around areola percent surround skin inflam patient report persist fever burn pain breast loxoscel final conclud surgic debrid undertaken follow supervis wound therapi local skin care complet heal achiev week treatment diagnosi loxoscel general presumpt bite usual painless spider rare captur diagnosi consid abscess respond poor antibiot | D001098;D013112 | T204;T037 |
34,686,398 | clear cell carcinoma comprehens literatur review case comprehens literatur review repres summari case clear cell carcinoma ccc salivari gland document literatur pubm use collect avail report ccc report detail case publish retriev clinic tumor manifest common painless mass swell palat durat symptom prior seek care rang week year metastasi local distant report total case local tumor recurr present case histopatholog ccc show mixtur growth pattern includ solid nest sheet like cord trabecula immunohistochem studi posit one cytokeratin pas ema p negat pasd sma calponin molecular featur report case posit ewsr rearrang ewsr break apart fish test posit rearrang ewsr atf test qpcr target rna sequenc clinic pattern genet studi impli tumor extraoss counterpart clear cell odontogen carcinoma intraoss odontogen tumor jaw | D018262;D012468 | T191 |
34,686,397 | risk stratif poor health relat qualiti life follow head neck cancer aid one page item prompt list aim work evalu usabl singl page patient complet condit specif prompt list patient concern inventori pci hn risk stratifi poor health relat qualiti life hrqol data collect main dataset compris patient first complet pci hn univers washington qualiti life questionnair uw qolv anoth patient first complet pci hn provid second dataset independ valid subsequ complet pci hn group distress thermomet dt also use valid dataset associ pci hn item select patient rang uw qolv outcom explor use convent logist regress chi squar autom interact detect chaid analys one quarter patient report less good hrqol rang across four dataset sever individu item within pci hn predict advers outcom total number item select also predict singl sheet prompt list enabl clinician identifi patient high risk poor hrqol simpl approach potenti integr routin clinic practic | D006258;D062645 | T191;T061 |
34,686,396 | lower serum selenium concentr associ anxieti children studi examin role selenium anxieti studi aim evalu associ serum selenium concentr anxieti disord symptom children | D016584;D012643 | T048;T121;T196;T123 |
34,686,394 | estim vaccin threshold impact hepat virus outbreak among person experienc homeless use drug louisvill kentucki unit state septemb june outbreak hepat virus hav occur louisvill kentucki result case death predomin among person experi homeless use drug pehpwud critic vaccin threshold v c requir achiev herd immun popul unknown investig v c vaccin impact use epidem model | D006506;D030041;D006703;D004364 | T047;T121;T098;T005;T095;T033 |
34,686,391 | character novel semi interpenetr hydrogel network fabric polyethylen glycol diacrylatepolyvinyl alcoholtragacanth gum wound dress research novel semi interpenetr hydrogel network compris polyethylen glycol diacryl pegda polyvinyl alcohol pva tragacanth gum tg adapt mechan biolog physic characterist fabric wound heal purpos chemic structur film surfac morpholog examin ftir sem respect addit swell ratio mechan characterist water vapor transmiss rate wvtr gel fraction degrad hydrogel assess evalu cytocompat mtt assay cell attach studi perform ftir result show vinyl peak elimin crosslink pegda chain result also show incorpor pva network increas swell ration decreas poros furthermor ratio pegda pva increas wvtr ratio cell adhes elong network increas also found amount pegda reduc degrad rate network decreas result verifi non toxic natur pegdapvatg hydrogel network final antibacteri result demonstr highest antibacteri activ bacteri pathogen relat tg contain film therefor pegdapvatg hydrogel network favor wound dress | D002056;D014144 | T109;T121;T037;T123 |
34,686,390 | pain manag bromelain base select enzymat debrid paediatr adult burn patient pain associ surgic enzymat burn wound debrid prevent mani burn centr work outsid oper theatr creat burden altern general anaesthesia manag pain burn patient treat enzymat debrid region anaesthesia studi detail studi explor differ possibl pain manag bedsid nexobrid procedur | D001963;D002056 | T116;T121;T126;T037 |
34,686,389 | associ relat grip strength risk cancer site grip strength common use muscl strength proxi clinic research howev evid regard associ grip strength cancer main restrict overal cancer risk therefor studi aim evalu associ grip strength relat bmi cancer site well caus cancer mortal | D018737;D009369 | T040;T191;T081 |
34,686,388 | systemat review self measur blood pressur monitor support intervent effect cost self measur blood pressur monitor support evid base intervent help patient control blood pressur systemat econom review describ certain intervent aspect contribut effect intervent cost intervent cost per unit effect self measur blood pressur monitor support | D001795 | T058 |
34,686,387 | effici side effect novel method maxillari central root torqu horizont box loop round wire comparison convent rectangular wire finit element studi appli root torqu use convent method rectangular wire side effect invers destruct forc undesir torqu adjac teeth heavi forc limit rang durat need mani session introduc new method horizont box loop hbl design reduc mani side effect test effici side effect use finit element analysi | D016910;D009969 | T074 |
34,686,386 | rectourethr fistula induc localis prostat cancer treatment surgic function outcom transperin repair gracili muscl flap interposit transperin repair rectourethr fistula ruf follow prostat cancer treatment gracili muscl flap interposit gmfi lead favour outcom publish data still lack notabl concern function aspect | D000071976;D011471;D012003;D014522;D014548;D014549 | T191;T047;T023;T046;T190;T020 |
34,686,384 | rectifi sluggish outer hair cell regul rather amplifi cochlea mechano electr transduct preced dynam rang compress outer hair cell ohc voltag depend length chang known electromotil play central role compress process exact mechan poor understood review old new experiment find show audibl high frequenc tone evok microvolt ac receptor potenti basal ohc mechan amplif soft high frequenc tone ohc motil would advers effect audibl higher basolater k conduct increas ohc corner frequenc boost magnitud high frequenc ac receptor potenti ohc receptor current display substanti rectifi dc compon mechan dc respons baselin shift acoust stimuli insignific basilar membran compar magnitud ac respons record organ corti apex base basal turn dc compon may even exceed ac compon lend support dallo suggest apic basal ohc display signific degre rectif show low intens cochlear travel wave virtu abrupt transit fast slow propag well suit transport high frequenc energi minim loss db loss khz tone gerbil db khz tone transmit without loss tonotop place would evok destruct displac amplitud nm interpret find framework local dissip regul ohc motil articl part special issu outer hair cell edit joseph santo sacchi kumar navaratnam | D018072;D018069 | T025 |
34,686,383 | antinuclear antibodi patient endometriosi cross section studi patient marker autoimmun autoantibodi found patient endometriosi includ antinuclear antibodi ana aim evalu preval ana sampl patient endometriosi possibl clinic associ nineti four patient endometriosi control studi ana extract nuclear antigen ena anti ro anti la anti sm anti rnp profil anti dsdna epidemiolog clinic stage data endometriosi obtain patient autoimmun disord exclud patient endometriosi preval posit ana vs control p ena profil anti dsdna negat patient posit ana asymptomat p less dysmenorrhea associ diseas durat patient age endometriosi stage found found high preval posit ana patient endometriosi presenc autoantibodi may link milder clinic express diseas | D001327;D004715 | T191;T047 |
34,686,382 | methodolog choic experiment research medic communic use vignett impact gender congruenc vignett modal experiment vignett design use systemat test effect medic communic test impact two methodolog choic gender congruenc vignett modal analogu patient report outcom | D003142;D010817 | T097;T080;T170;T054 |
34,686,381 | develop question prompt list oncolog set scope review purpos studi provid overview exist method use develop question prompt list qpl oncolog set | D009369;D010817 | T191;T054 |
34,686,379 | reduct post oper opioid use neonat follow open congenit diaphragmat hernia repair qualiti improv initi limit number post oper opioid reduct strategi implement neonat popul given potenti neurodevelop effect prolong opioid use creat qualiti improv initi reduc opioid nicu evalu intervent cdh popul | D000701;D065630 | T019;T131;T121;T109 |
34,686,378 | analysi american physician profession statement gun violenc children examin content physician profession associ statement assess extent statement kept gun violenc especi children policymak agenda | D005389;D000078402;D010820;D014948 | T097;T068;T037;T073 |
34,686,377 | outcom telemedicin bowel manag program covid due covid pandem transit person bowel manag program bmp telemedicin bmp telemedicin bmp consist video andor phone call visit remot singl initi person visit follow remot visit hybrid hypothes patientfamili satisfact telemedicin bmp would compar person bmp would improv qualiti life function outcom telemedicin bmp | D000086382;D017216 | T058;T047;T067 |
34,686,376 | commentari ethic dilemma manag infant enterocol totali commentari manuscript titl ethic dilemma manag infant necrot enterocol totali pennington e javid p mueller c et al | D020345;D007232 | T047 |
34,686,375 | long term assess bilirubin transaminas trend pediatr intestin failur patient era hepatoprotect parenter nutrit studi aim character relationship hepatoprotect parenter nutrit pn depend long term serum liver test children intestin failur | D007410;D000090124 | T047 |
34,686,372 | associ matern serum albumin level fetal growth fetal growth restrict term born singleton prospect cohort studi investig associ matern serum albumin malb level fetal growth fetal growth restrict fgr risk term born singleton | D047109;D000068097 | T039;T038;T081 |
34,686,371 | team excel challeng collabor world reproduct clinic translat research succeed conduct clinic trial reproduct medicin team must train cultiv collabor achiev common goal share person experi lesson learn team research set cover topic time manag resourc alloc collabor publish communic | D003299 | T054 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.